Feedback / Questions
elisrasib (D3S-001) - D3 Bio
D3S-003 - D3 Bio
D3S-002 - D3 Bio
https://www.prnewswire.com/news-releases/d3-bio-receives-us-fda-clearance-for-two-ind-applications-enabling-phase-1-trial-of-d3s003-and-phase-2-combination-study-of-elisrasib-d3s001-with-d3s002-302664022.html
Jan 18, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next